Literature DB >> 19672984

LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.

Zijuan Zhang1, Jean-Marc Burgunder, Xingkai An, Yan Wu, Wenjun Chen, Jinhong Zhang, Yingcheng Wang, Yanming Xu, Yingru Gou, Guanggu Yuan, Xueye Mao, Rong Peng.   

Abstract

Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2 (LRRK2), are associated with autosomal dominant and sporadic forms of Parkinson's disease (PD) and are the most common genetic causes of PD. Recently, a R1628P variant has been reported as a risk factor for PD in Taiwan and Singapore. To determine the association of this variant and PD in the Han-Chinese population from mainland China, we analyzed its frequency in a cohort of 600 patients and 459 unrelated healthy controls. Forty (6.7%) patients were heterozygous and 3 (0.5%) homozygous for the R1628P variant, which was significantly more frequent than in the controls [2.4% heterozygous and 0.0% homozygous, Odds ratio = 3.14, 95%CI: 1.60-6.17, P < 0.01]. Considering the age at onset, this difference was found only in late-onset PD (older than 50) [Odds ratio = 3.76, 95% CI: 1.90-7.45, P < 0.01]. Our data confirms that the LRRK2 R1628P variant is associated with an increased risk to develop late onset PD in the ethnic Han-Chinese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672984     DOI: 10.1002/mds.22371

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

Review 1.  Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes.

Authors:  Amrita Kabi; Kourtney P Nickerson; Craig R Homer; Christine McDonald
Journal:  Inflamm Bowel Dis       Date:  2011-09-20       Impact factor: 5.325

2.  Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China.

Authors:  Jiangping Cai; Yi Lin; Wanjin Chen; Qifang Lin; Bin Cai; Ning Wang; Weihong Zheng
Journal:  Neurol Sci       Date:  2013-04-30       Impact factor: 3.307

Review 3.  Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications.

Authors:  Iakov N Rudenko; Mark R Cookson
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

4.  LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.

Authors:  Soraya Bardien; Angelica Marsberg; Rowena Keyser; Debbie Lombard; Suzanne Lesage; Alexis Brice; Jonathan Carr
Journal:  J Neural Transm (Vienna)       Date:  2010-06-11       Impact factor: 3.575

Review 5.  Gene-environment interactions: key to unraveling the mystery of Parkinson's disease.

Authors:  Hui-Ming Gao; Jau-Shyong Hong
Journal:  Prog Neurobiol       Date:  2011-03-23       Impact factor: 11.685

6.  Analysis on the susceptibility genes in two chinese pedigrees with familial Parkinson's disease.

Authors:  Changshui Xu; Jun Xu; Yanmin Zhang; Jianjun Ma; Hideshi Kawakami; Hirofumi Maruyama; Masaki Kamada
Journal:  Neurol Res Int       Date:  2010-08-23

Review 7.  The role of the LRRK2 gene in Parkinsonism.

Authors:  Jie-Qiong Li; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurodegener       Date:  2014-11-12       Impact factor: 14.195

8.  Association of LRRK2 R1628P variant with Parkinson's disease in Ethnic Han-Chinese and subgroup population.

Authors:  Pei Zhang; Qingzhi Wang; Fengjuan Jiao; Jianguo Yan; Lijun Chen; Feng He; Qian Zhang; Bo Tian
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

Review 9.  LRRK2: cause, risk, and mechanism.

Authors:  Coro Paisán-Ruiz; Patrick A Lewis; Andrew B Singleton
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

10.  LRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson's disease in the Malaysian population.

Authors:  Aroma Agape Gopalai; Shen-Yang Lim; Jing Yi Chua; Shelisa Tey; Thien Thien Lim; Norlinah Mohamed Ibrahim; Ai Huey Tan; Gaik Bee Eow; Zariah Abdul Aziz; Santhi Datuk Puvanarajah; Shanthi Viswanathan; Irene Looi; Soo Kun Lim; Li Ping Tan; Yip Boon Chong; Chong Tin Tan; Yi Zhao; E K Tan; Azlina Ahmad-Annuar
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.